Sickle Cell Disease Drug Market Report

China Sickle Cell Disease Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 22, 2023
  • PAGES：147
  • REPORT CODE：GMM1750859
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Sickle Cell Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Global Blood Therapeutics Inc

    • Angiocrine Bioscience Inc

    • Errant Gene Therapeutics LLC

    • Gilead Sciences Inc

    • Annexin Pharmaceuticals AB

    • Bristol-Myers Squibb Co

    • Daiichi Sankyo Co Ltd

    • bluebird bio Inc

    • Acceleron Pharma Inc

    • Editas Medicine Inc

    • Bio Products Laboratory Ltd

    • Calimmune Inc

    • Gamida Cell Ltd

    • Genethon SA

    • CSL Ltd

    • Addmedica SAS

    By Type:

    • CTX-001

    • DRX-194

    • CAL-H

    • ARQ-092

    • BIVV-003

    • Others

    By Application:

    • Hospital

    • Others

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Sickle Cell Disease Drug Market Overview 2018-2029

    • 1.1 China Sickle Cell Disease Drug Industry Development Overview

    • 1.2 China Sickle Cell Disease Drug Industry Development History

    • 1.3 China Sickle Cell Disease Drug Industry Market Size (2018-2029)

    • 1.4 China Sickle Cell Disease Drug Market Analysis by Type from Production Side

      • 1.4.1 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of CTX-001 (2018-2029)

      • 1.4.2 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of DRX-194 (2018-2029)

      • 1.4.3 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of CAL-H (2018-2029)

      • 1.4.4 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of ARQ-092 (2018-2029)

      • 1.4.5 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of BIVV-003 (2018-2029)

      • 1.4.6 China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Sickle Cell Disease Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Sickle Cell Disease Drug Market Analysis by Region

      • 1.6.1 North China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Sickle Cell Disease Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Sickle Cell Disease Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Sickle Cell Disease Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Sickle Cell Disease Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Sickle Cell Disease Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Sickle Cell Disease Drug Industry Development

    Chapter 3 Sickle Cell Disease DrugIndustry Chain Analysis

    • 3.1 Sickle Cell Disease Drug Industry Chain

    • 3.2 Sickle Cell Disease Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Sickle Cell Disease Drug Market

    • 3.3 Sickle Cell Disease Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Sickle Cell Disease Drug Market

    Chapter 4 China Sickle Cell Disease Drug Market, by Type

    • 4.1 China Sickle Cell Disease Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Sickle Cell Disease Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Sickle Cell Disease Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Sickle Cell Disease Drug Production Volume and Growth Rate of CTX-001

      • 4.5.2 China Sickle Cell Disease Drug Production Volume and Growth Rate of DRX-194

      • 4.5.3 China Sickle Cell Disease Drug Production Volume and Growth Rate of CAL-H

      • 4.5.4 China Sickle Cell Disease Drug Production Volume and Growth Rate of ARQ-092

      • 4.5.5 China Sickle Cell Disease Drug Production Volume and Growth Rate of BIVV-003

      • 4.5.6 China Sickle Cell Disease Drug Production Volume and Growth Rate of Others

    Chapter 5 China Sickle Cell Disease Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Sickle Cell Disease Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Sickle Cell Disease Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Sickle Cell Disease Drug Market Size and Growth Rate of Hospital

      • 5.5.2 China Sickle Cell Disease Drug Market Size and Growth Rate of Others

      • 5.5.3 China Sickle Cell Disease Drug Market Size and Growth Rate of Clinic

    Chapter 6 China Sickle Cell Disease Drug Market, by Region

    • 6.1 China Sickle Cell Disease Drug Production Volume and Production Value, by Region

    • 6.2 China Sickle Cell Disease Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Sickle Cell Disease Drug Market Analysis

    • 7.1 North China Sickle Cell Disease Drug Market, by Type

    • 7.2 North China Sickle Cell Disease Drug Market, by Application

    Chapter 8 Central China Sickle Cell Disease Drug Market Analysis

    • 8.1 Central China Sickle Cell Disease Drug Market, by Type

    • 8.2 Central China Sickle Cell Disease Drug Market, by Application

    Chapter 9 South China Sickle Cell Disease Drug Market Analysis

    • 9.1 South China Sickle Cell Disease Drug Market, by Type

    • 9.2 South China Sickle Cell Disease Drug Market, by Application

    Chapter 10 East China Sickle Cell Disease Drug Market Analysis

    • 10.1 East China Sickle Cell Disease Drug Market, by Type

    • 10.2 East China Sickle Cell Disease Drug Market, by Application

    Chapter 11 Northeast China Sickle Cell Disease Drug Market Analysis

    • 11.1 Northeast China Sickle Cell Disease Drug Market, by Type

    • 11.2 Northeast China Sickle Cell Disease Drug Market, by Application

    Chapter 12 Southwest China Sickle Cell Disease Drug Market Analysis

    • 12.1 Southwest China Sickle Cell Disease Drug Market, by Type

    • 12.2 Southwest China Sickle Cell Disease Drug Market, by Application

    Chapter 13 Northwest China Sickle Cell Disease Drug Market Analysis

    • 13.1 Northwest China Sickle Cell Disease Drug Market, by Type

    • 13.2 Northwest China Sickle Cell Disease Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Global Blood Therapeutics Inc

        • 14.1.1 Global Blood Therapeutics Inc Company Profile

        • 14.1.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Angiocrine Bioscience Inc

        • 14.2.1 Angiocrine Bioscience Inc Company Profile

        • 14.2.2 Angiocrine Bioscience Inc Sickle Cell Disease Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Errant Gene Therapeutics LLC

        • 14.3.1 Errant Gene Therapeutics LLC Company Profile

        • 14.3.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Gilead Sciences Inc

        • 14.4.1 Gilead Sciences Inc Company Profile

        • 14.4.2 Gilead Sciences Inc Sickle Cell Disease Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Annexin Pharmaceuticals AB

        • 14.5.1 Annexin Pharmaceuticals AB Company Profile

        • 14.5.2 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bristol-Myers Squibb Co

        • 14.6.1 Bristol-Myers Squibb Co Company Profile

        • 14.6.2 Bristol-Myers Squibb Co Sickle Cell Disease Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Daiichi Sankyo Co Ltd

        • 14.7.1 Daiichi Sankyo Co Ltd Company Profile

        • 14.7.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 bluebird bio Inc

        • 14.8.1 bluebird bio Inc Company Profile

        • 14.8.2 bluebird bio Inc Sickle Cell Disease Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Acceleron Pharma Inc

        • 14.9.1 Acceleron Pharma Inc Company Profile

        • 14.9.2 Acceleron Pharma Inc Sickle Cell Disease Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Editas Medicine Inc

        • 14.10.1 Editas Medicine Inc Company Profile

        • 14.10.2 Editas Medicine Inc Sickle Cell Disease Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Bio Products Laboratory Ltd

        • 14.11.1 Bio Products Laboratory Ltd Company Profile

        • 14.11.2 Bio Products Laboratory Ltd Sickle Cell Disease Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Calimmune Inc

        • 14.12.1 Calimmune Inc Company Profile

        • 14.12.2 Calimmune Inc Sickle Cell Disease Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Gamida Cell Ltd

        • 14.13.1 Gamida Cell Ltd Company Profile

        • 14.13.2 Gamida Cell Ltd Sickle Cell Disease Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Genethon SA

        • 14.14.1 Genethon SA Company Profile

        • 14.14.2 Genethon SA Sickle Cell Disease Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 CSL Ltd

        • 14.15.1 CSL Ltd Company Profile

        • 14.15.2 CSL Ltd Sickle Cell Disease Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Addmedica SAS

        • 14.16.1 Addmedica SAS Company Profile

        • 14.16.2 Addmedica SAS Sickle Cell Disease Drug Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Sickle Cell Disease Drug Industry Research Conclusions

    • 15.2 Sickle Cell Disease Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Sickle Cell Disease Drug Industry Market Size (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of CTX-001 (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of DRX-194 (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of CAL-H (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of ARQ-092 (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of BIVV-003 (2018-2029)

    • Figure China Sickle Cell Disease Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Sickle Cell Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Sickle Cell Disease Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Sickle Cell Disease Drug Market Share by Type in 2018

    • Figure China Sickle Cell Disease Drug Market Share by Type in 2023

    • Figure China Sickle Cell Disease Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of CTX-001 (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of DRX-194 (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of CAL-H (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of ARQ-092 (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of BIVV-003 (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Sickle Cell Disease Drug Market Share by Application in 2018

    • Figure China Sickle Cell Disease Drug Market Share by Application in 2023

    • Figure China Sickle Cell Disease Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Sickle Cell Disease Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Sickle Cell Disease Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Sickle Cell Disease Drug Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Sickle Cell Disease Drug Production Volume by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Production Volume Share by Region (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Volume Share by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Production Value by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Production Value Share by Region (2018-2023)

    • Figure China Sickle Cell Disease Drug Production Value Share by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Sales Volume by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Sales Volume Share by Region (2018-2023)

    • Figure China Sickle Cell Disease Drug Sales Volume Share by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Sales Value by Region (2018-2023)

    • Table China Sickle Cell Disease Drug Sales Value Share by Region (2018-2023)

    • Figure China Sickle Cell Disease Drug Sales Value Share by Region (2018-2023)

    • Table North China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table North China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure North China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table North China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table North China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table Central China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table Central China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table Central China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table South China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table South China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure South China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table South China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table South China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table East China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table East China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure East China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table East China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table East China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table Northeast China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table Southwest China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Sickle Cell Disease Drug Production Volume by Type (2018-2023)

    • Table Northwest China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Sickle Cell Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Sickle Cell Disease Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Sickle Cell Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Global Blood Therapeutics Inc Company Profile

    • Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Angiocrine Bioscience Inc Company Profile

    • Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Errant Gene Therapeutics LLC Company Profile

    • Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Inc Company Profile

    • Table Gilead Sciences Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Annexin Pharmaceuticals AB Company Profile

    • Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Co Company Profile

    • Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Co Ltd Company Profile

    • Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table bluebird bio Inc Company Profile

    • Table bluebird bio Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Acceleron Pharma Inc Company Profile

    • Table Acceleron Pharma Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Editas Medicine Inc Company Profile

    • Table Editas Medicine Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Bio Products Laboratory Ltd Company Profile

    • Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Calimmune Inc Company Profile

    • Table Calimmune Inc Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Gamida Cell Ltd Company Profile

    • Table Gamida Cell Ltd Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Genethon SA Company Profile

    • Table Genethon SA Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table CSL Ltd Company Profile

    • Table CSL Ltd Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Addmedica SAS Company Profile

    • Table Addmedica SAS Sickle Cell Disease Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US